Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 4BC account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 4BC content and other benefits.


Joining is easy.

Advertisement
Advertisement
Advertisement

Dr Edwin Szeto: Theranostics Service and Lutetium-PSMA therapy

John Stanley

The San has recently welcomed to its Radiology and Nuclear medicine department a new service – Theranostics.

Theranostics is a personalised approach to treating cancer using both therapy and diagnostics. The first therapy that will be used by the service is for men with advanced prostate cancer called Lutetium-177 Prostate Specific Membrane Antigen aka “Lutetium-PSMA” therapy. This therapy is used when the disease has spread, and other treatments have failed or been poorly tolerated.

The theranostics service at San Radiology & Nuclear Medicine commenced in March 2021, with a dedicated theranostics area within the imaging department which will enable the dedicated team to treat up to three patients at any one time in a safe and comfortable environment.

San Nuclear Medicine Physician Dr Edwin Szeto joins John Stanley.

Download this podcast here

John Stanley
Advertisement